magnesium carbonate has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aires, I; Amaral, T; Azevedo, A; Ferreira, A; Ferreira, C; Gil, C; Jorge, C; Laranjinha, I; Matias, PJ; Mendes, M; Navarro, D; Stuard, S | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
1 review(s) available for magnesium carbonate and Cardiovascular Diseases
| Article | Year |
|---|---|
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
1 other study(ies) available for magnesium carbonate and Cardiovascular Diseases
| Article | Year |
|---|---|
Calcium Acetate/Magnesium Carbonate and Cardiovascular Risk Factors in Chronic Hemodialysis Patients.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Compounds; Cardiovascular Diseases; Humans; Magnesium; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors | 2016 |